Compile Data Set for Download or QSAR
maximum 50k data
Found 177 with Last Name = 'st-onge' and Initial = 'm'
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591018(CHEMBL5204203)
Affinity DataIC50:  0.0680nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591016(CHEMBL5175156)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591017(CHEMBL5206022)
Affinity DataIC50:  0.400nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591022(CHEMBL5197367)
Affinity DataIC50:  0.510nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591035(CHEMBL5187422)
Affinity DataIC50:  0.550nMAssay Description:Inhibition of N-terminal His8-tagged/C-terminal FLAG-tagged full length human DNA polymerase theta ( 1 to 2590 residues) polymerase activity expresse...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591030(CHEMBL5174509)
Affinity DataIC50:  0.720nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591026(CHEMBL5197173)
Affinity DataIC50:  0.75nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591015(CHEMBL5170373)
Affinity DataIC50:  0.820nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591028(CHEMBL5194637)
Affinity DataIC50:  0.910nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591027(CHEMBL5197021)
Affinity DataIC50:  0.990nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591019(CHEMBL5187337)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591024(CHEMBL5188048)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591033(CHEMBL5181369)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591029(CHEMBL5174376)
Affinity DataIC50:  1.70nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591032(CHEMBL5200250)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591021(CHEMBL5174283)
Affinity DataIC50:  2.5nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591020(CHEMBL5195161)
Affinity DataIC50:  2.90nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591023(CHEMBL5194194)
Affinity DataIC50:  3.90nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591034(CHEMBL5206029)
Affinity DataIC50:  4.20nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591031(CHEMBL5202450)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591035(CHEMBL5187422)
Affinity DataIC50:  5.80nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  7.5nMAssay Description:Inhibition of human DNA polymerase theta using DNA 16/19 as substrate at 1 nM of enzyme concentrationMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  8.5nMAssay Description:Inhibition of human DNA polymerase theta using DNA 16/19 as substrate at 0.5 nM of enzyme concentrationMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  8.70nMAssay Description:Inhibition of human DNA polymerase theta using DNA 16/19 as substrate at 2 nM of enzyme concentrationMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591025(CHEMBL5200171)
Affinity DataIC50:  9nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  10nMAssay Description:Inhibition of human DNA polymerase theta using 5'-CACTGACTGTATGATG as primer and DNA 16/19 as substrate by FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  11nMAssay Description:Inhibition of human DNA polymerase theta using DNA 16/19 as substrate at 5 nM of enzyme concentrationMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591014(CHEMBL5178605)
Affinity DataIC50:  14nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591003(CHEMBL5203967)
Affinity DataIC50:  14nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645627(US20240018138, Compound 104 | US20240018138, Compo...)
Affinity DataIC50:  15.1nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591012(CHEMBL5185359)
Affinity DataIC50:  17nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591002(CHEMBL5195920)
Affinity DataIC50:  17nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591012(CHEMBL5185359)
Affinity DataIC50:  19nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645624(US20240018138, Compound 102)
Affinity DataIC50:  27.2nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591006(CHEMBL5178606)
Affinity DataIC50:  40nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591013(CHEMBL5206197)
Affinity DataIC50:  42nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645627(US20240018138, Compound 104 | US20240018138, Compo...)
Affinity DataIC50:  51.7nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645631(US20240018138, Compound 107)
Affinity DataIC50:  51.8nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591008(CHEMBL5208584)
Affinity DataIC50:  58nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645632(US20240018138, Compound 108)
Affinity DataIC50:  62.3nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591007(CHEMBL5181730)
Affinity DataIC50:  65nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591005(CHEMBL5200543)
Affinity DataIC50:  121nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645655(US20240018138, Compound 123)
Affinity DataIC50:  133nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645640(US20240018138, Compound 116)
Affinity DataIC50:  157nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50590990(CHEMBL5185248)
Affinity DataIC50:  170nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645648(US20240018138, Compound 122)
Affinity DataIC50:  205nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645641(US20240018138, Compound 117)
Affinity DataIC50:  221nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase(Homo sapiens)
Ventus Therapeutics U.S.

US Patent
LigandPNGBDBM645636(US20240018138, Compound 112)
Affinity DataIC50:  236nMAssay Description:Certain compounds of the present disclosure were tested for their h-cGAS inhibition activity using the methodology reported in Lama et al., “Dev...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA polymerase theta(Homo sapiens)
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50590997(CHEMBL5175626)
Affinity DataIC50:  240nMAssay Description:Inhibition of human DNA polymerase theta pol domain (1819 to 2590 residues) expressed in Escherichia coli BL21 (DE3) cells preincubated for 15 mins f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50021820(CHEMBL3297778)
Affinity DataIC50:  310nMAssay Description:Antagonist activity at human TRPA1 expressed in HEK293-TREx cells assessed as intracellular level after 48 of 72 hrs by Fluo-4 NW staining-based fluo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 177 total ) | Next | Last >>
Jump to: